Milhealth's Directory of Military Health Information Resources

Psychopharmacological Treatment for Cognitive Impairment in Survivors of Traumatic Brain Injury

Psychopharmacological Treatment for Cognitive Impairment in Survivors of Traumatic Brain Injury: A Critical Review

Traumatic brain injury (TBI) is a growing national health issue that commonly results in clinically significant cognitive impairments. This article reviews and evaluates the many proposed psychopharmacological treatments for TBI-related cognitive impairment.

Prehospital treatment guidelines in severe traumatic brain injury-What really happens outside the hospital?

Prehospital treatment guidelines in severe traumatic brain injury: What really happens outside the hospital?

No abstract is available.

AUTHORS: Gaby Franschman, Sjoerd Greuters, Stephan A. Loer, Christa Boer

CITATIONS:

Hudetz JA, Pagel PS. Neuroprotection by ketamine: a review of the experimental and clinical evidence. J. Cardiothorac. Vasc. Anesth. 2010;24(1):131-142. Available at: http://www.ncbi.nlm.nih.gov/pubmed/19640746 [Accessed February 10, 2010].

http://bit.ly/bhP4pa

d-Cycloserine improves functional outcome after traumatic brain injury with wide therapeutic window

Neuropharmacology and Analgesia

d-Cycloserine improves functional outcome after traumatic brain injury with wide therapeutic window

Abstract

It has been long thought that hyperactivation of N-methyl-d-aspartate (NMDA) receptors underlies neurological decline after traumatic brain injury. However, all clinical trials with NMDA receptor antagonists failed. Since NMDA receptors are down-regulated from 4 h to 2 weeks after brain injury, activation at 24 h, rather than inhibition, of these receptors, was previously shown to be beneficial in mice.

Developing a Window into the Brain for Traumatic Injury Diagnosis-BlogTalkRadio

Armed with Science on Blog Talk Radio

Episode #53: Developing a “Window into the Brain” for Traumatic Injury Diagnosis

Adult cell therapy for brain neuronal damages and the role of tissue engineering

Review

Adult cell therapy for brain neuronal damages and the role of tissue engineering

ABSTRACT

No long term effective treatments are currently available for brain neurological disorders such as stroke/cerebral ischemia, traumatic brain injury and neurodegenerative disorders.